CalciMedica Subsidiary
La Jolla, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
KA
Kenneth A. StaudermanExecutive Officer
AR
A. Rachel LehenyExecutive Officer, Director
DG
Daniel GeffkenExecutive Officer
SH
Sudarshan HebbarExecutive Officer
EW
Eric W. RobertsExecutive Officer
MJ
Michael J. DunnExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$10.3MraisedApr 2023 · 8 investors · BiotechnologyRule 506(b)
▶$10.3MraisedApr 2023 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kenneth A. StaudermanExecutive Officer
- A. Rachel LehenyExecutive Officer, Director
- Daniel GeffkenExecutive Officer
- Sudarshan HebbarExecutive Officer
- Eric W. RobertsExecutive Officer
- Michael J. DunnExecutive Officer, Director
- Offering amount
- $10.3M
- Amount sold
- $10.3M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17.2MraisedMay 2020 · 12 investors · BiotechnologyRule 506(b)
▶$17.2MraisedMay 2020 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert G. McNeilDirector
- Lakmir ChawlaDirector
- A. Rachel LehenyExecutive Officer, Director
- Fred MiddletonDirector
- Robert WilsonDirector
- Eric RobertsExecutive Officer, Director
- Michael DunnExecutive Officer, Director
- Offering amount
- $17.2M
- Amount sold
- $17.2M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.